Healwell AI Inc. develops clinical decision support systems utilizing artificial intelligence for the healthcare sector across several countries. The company boasts strong gross (54.4%) and EBITDA margins (47.5%), indicating efficient operations. However, a relatively low return on equity (4.9%) and return on assets (2.2%) raise concerns about profitability relative to shareholder equity and total assets. Additionally, while the margins are high, the stock price of $0.68 suggests potential undervaluation, warranting further investigation into market perceptions and growth prospects.
Loading financial metrics...
Company posted a loss of $-30.1M over the last year, representing 23.4% of revenue.
Exceptional revenue growth of 54.1% YoY demonstrates strong market demand and competitive positioning.
Gross margin expanded by 38.6 percentage points, indicating improved pricing power or cost efficiency.
Operating margin expanded by 114.0pp, demonstrating strong operational leverage.
Both gross margin (+38.6pp) and operating margin (+114.0pp) are expanding simultaneously, indicating the company is scaling profitably.
Strong gross margin of 55.6% reflects healthy unit economics.
Valuation, risk assessment, competitive positioning, and key insights — all in one report.
Other Medical Care Facilities companies of a similar size
Based on 2026-Q2 (June 30, 2026)